Abnormal myocardial cytoskeletal proteins in patients with end-stage dilated cardiomyopathy

QIN Shengmei,WANG Qibing,ZHUANG Yamin,LI Gaoping,WANG Chunsheng,CHEN Hao,YANG Yingzhen,GE Junbo,CHEN Haozhu
DOI: https://doi.org/10.3969/j.issn.1001-1439.2007.07.002
2007-01-01
Journal of Clinical Cardiology
Abstract:Objective:To investigate myocardial cytoskeletal proteins including actin,desmin,sarcoglycans(α,β,γ,δ)in patients with dilated cardiomyopathy(DCM)and other end-stage heart diseases.Method:Nine patients(6 males,3 females,aged [34±16]years)with advanced DCM and 6 patients(5 males,1 female,aged [33±22]years)with other late-stage heart diseases including 2 cases of hypertrophic cardiomyopathy,1 ischemic cardiomyopathy,1 myocardial sarcoma,and 2 congenital heart diseases,and 1 non-cardiac brain-death patient were examined on left ventricular tissues by immunohistochemical study.Result:Immunohistochemical study showed 8 of 9 patients with DCM were found abnormal myocardial cytoskeletal proteins(actin,desmin,sarcoglycans),manifesting disruption or reduction of cytoskeletal protein,in which at least 1 sub-type of sarcoglycans was abnormally expressed in the 8 patients,meanwhile,abnormal actin and/or desmin expression were demonstrated in 5 patients.Whereas,4 of 6 non-DCM subjects,with NYHA grade IV,showed abnormal cytoskeletal proteins including 1 case of α-sarcoglycan,1 case of δ-sarcoglycan,1 case of actin and α,β-sarcoglycan,and 1 case of actin abnormality.As control,the non-cardiac brain death patient was found normal cytoskeletal protein.Conclusion:Abnormal cytoskeletal proteins like actin,desmin,sarcoglycans were expressed with reduction or disruption in failing myocardium DCM and other end-stage heart diseases,indicating that transmembrane force transmitting defects caused by abnormal cytoskeletal proteins mightbe the common underlying pathogenesis for end-stage heart diseases.
What problem does this paper attempt to address?